| Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment: analysis of 189 episodes F Vidal, J Mensa, M Almela, JA Martínez, F Marco, C Casals, JM Gatell, ... Archives of internal medicine 156 (18), 2121-2126, 1996 | 363 | 1996 |
| Genetic polymorphism of alcohol dehydrogenase in europeans: TheADH2* 2allele decreases the risk for alcoholism and is associated withADH3 E Borràs, C Coutelle, A Rosell, F Fernández-Muixi, M Broch, B Crosas, ... Hepatology 31 (4), 984-989, 2000 | 307 | 2000 |
| Do alcohol‐metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? E Zintzaras, I Stefanidis, M Santos, F Vidal Hepatology 43 (2), 352-361, 2006 | 265 | 2006 |
| Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ... Clinical infectious diseases 62 (5), 655-663, 2016 | 189 | 2016 |
| Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients M Laguno, C Cifuentes, J Murillas, S Veloso, M Larrousse, A Payeras, ... Hepatology 49 (1), 22-31, 2009 | 146 | 2009 |
| Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study J Mallolas, D Podzamczer, A Milinkovic, P Domingo, B Clotet, E Ribera, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (1), 29-36, 2009 | 119 | 2009 |
| Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in Spanish men: lack of association with alcoholism and alcoholic liver disease F Vidal, A Lorenzo, T Auguet, M Olona, M Broch, C Gutiérrez, C Aguilar, ... Journal of hepatology 41 (5), 744-750, 2004 | 108 | 2004 |
| Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients L Ruiz, R Paredes, G Gómez, J Romeu, P Domingo, N Pérez-Alvarez, ... Aids 21 (2), 169-178, 2007 | 107 | 2007 |
| Epigenome-wide association study of COVID-19 severity with respiratory failure MC de Moura, V Davalos, L Planas-Serra, D Alvarez-Errico, C Arribas, ... EBioMedicine 66, 2021 | 103 | 2021 |
| Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain MÁ Rodríguez-Arenas, I Jarrín, JD Amo, JA Iribarren, S Moreno, P Viciana, ... AIDS Research & Human Retroviruses 22 (8), 715-723, 2006 | 98 | 2006 |
| Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study RK Lodwick, CA Sabin, K Porter, B Ledergerber, A Van Sighem, ... The Lancet 376 (9738), 340-345, 2010 | 97 | 2010 |
| Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study DK Nomah, J Reyes-Urueña, Y Díaz, S Moreno, J Aceiton, A Bruguera, ... The Lancet HIV 8 (11), e701-e710, 2021 | 96 | 2021 |
| Impact of late presentation of HIV infection on short-, mid-and long-term mortality and causes of death in a multicenter national cohort: 2004–2013 P Sobrino-Vegas, S Moreno, R Rubio, P Viciana, JI Bernardino, ... Journal of Infection 72 (5), 587-596, 2016 | 96 | 2016 |
| Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy F Gutiérrez, S Padilla, M Masiá, JA Iribarren, S Moreno, P Viciana, ... Current HIV research 6 (2), 100-107, 2008 | 96 | 2008 |
| Severe neutropenia and thrombocytopenia associated with infliximab F Vidal, R Fontova, C Richart Annals of Internal Medicine 139 (3), W-63, 2003 | 91 | 2003 |
| Bacteraemia in adults due to glucose non‐fermentative Gram‐negative bacilli other than P. aeruginosa F Vidal, J Mensa, M Almela, M Olona, JA Martinez, F Marco, MJ Lopez, ... Qjm 96 (3), 227-234, 2003 | 88 | 2003 |
| In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cells F Vidal, JC Domingo, J Guallar, M Saumoy, B Cordobilla, ... Antimicrobial agents and chemotherapy 50 (11), 3824-3832, 2006 | 85 | 2006 |
| Primary resistance to integrase strand-transfer inhibitors in Europe M Casadellà, PM Van Ham, M Noguera-Julian, A vAn Kessel, C Pou, ... Journal of antimicrobial chemotherapy 70 (10), 2885-2888, 2015 | 81 | 2015 |
| Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997–2006 SP Cachafeiro, J Del Amo, JA Iribarren, M Salavert Lleti, F Gutiérrez, ... Clinical infectious diseases 48 (10), 1467-1470, 2009 | 79 | 2009 |
| Pseudomonas aeruginosa Bacteremia in Patients Infected with Human Immunodeficiency Virus Type 1 F Vidal, J Mensa, JA Martinez, M Almela, F Marco, JM Gatell, C Richart, ... European Journal of Clinical Microbiology and Infectious Diseases 18, 473-477, 1999 | 77 | 1999 |
